Healio Gastroenterology Current Issue
The following articles appeared in the print edition of Healio Gastroenterology.
Table of Contents
- ‘Having women at the top’ drives structural change, advances gender equity in GI Kate Burba
-
- The pursuit of gender equity in GI: ‘We must move together’ with a growth mindset Anita Afzali, MD, MPH, MHCM, FACG, AGAF
- Livdelzi reduces cholestatic, liver injury markers in patients with PBC and cirrhosis Kate Burba
- AGA updates living guideline on pharmacological management of moderate to severe UC Kate Burba
- Angiotensin receptor blockers ‘may not be safe,’ worsen outcomes for celiac disease Monica Stonehill
- Anthem retracts ‘morally abhorrent’ policy to put time limit on anesthesia during surgery Monica Stonehill
- Concomitant use of common medications does not significantly affect UC induction therapy Kate Burba
- ESSENCE: Semaglutide bests placebo in MASH resolution, fibrosis improvement at 72 weeks Monica Stonehill
- FDA approves Yesintek, sixth Stelara biosimilar; launch slated for February
-
- FDA: Ocaliva still linked to ‘serious liver injury’ in PBC, even without cirrhosis
- GLP-1s improve ALT in pediatric MASLD, could be ‘powerful option’ for some patients Kate Burba
- GLP-1s offer comparable weight loss to bariatric surgery with fewer side effects Kate Burba
- HCC incidence nearly 5-times higher among HBV, HDV coinfected patients with cirrhosis Kate Burba
- Mean arterial pressure target of 75 mmHg may boost survival in cirrhosis with septic shock Kate Burba
- Monthly efimosfermin offers ‘rapid, meaningful’ improvement for MASH, related fibrosis Monica Stonehill
- ‘Only one in six’ veterans with chronic HBV finish HDV testing despite severe disease risk Monica Stonehill
- Pharmacotherapy for alcohol use disorder ‘underutilized’ in at-risk populations Monica Stonehill
-
- Q&A: Women physicians need to ‘be at the table, advocate for changes’ to thrive in GI Monica Stonehill; Linda Nguyen, MD
- Risk for detecting CRC up to 13-times higher with fecal hemoglobin in prior negative FIT Kate Burba
- VIDEO: Outreach to underrepresented students key to cultivating diversity in GI Kate Burba; Kenneth Obi, MD, FASGE, FACG
- VIDEO: Rebyota effective in prevention of recurrent C. diff, even in higher risk patients Kate Burba; Timothy E Ritter, MD
- Zegocractin ‘holds promise’ for reducing organ failure, necrosis in acute pancreatitis Monica Stonehill